MILOSO MARIAROSARIA
- U08, Floor: 1, Room: 1030
Publications
Fermi, S., Malacrida, A., Molteni, L., Miloso, M., Cavaletti, G., Nicolini, G. (2025). SARM1 modulation by HDAC6 inhibition as a neuroprotective strategy in chemotherapy-induced peripheral neuropathy. Intervento presentato a: NeuroMi 2025: Milan Center for Neuroscience, Milano, Italia. Detail
Fermi, S., Malacrida, A., Molteni, L., Miloso, M., Cavaletti, G., Nicolini, G. (2025). Histone Deacetylase 6 Inhibitors: Mitigators Of Chemotherapy Induced Peripheral Neuropathy Via The NMNAT2/SARM1 Pathway Modulation. Intervento presentato a: 2025 PNS Annual Meeting, Edinburgh, Scotland. Detail
Fermi, S., Malacrida, A., Molteni, L., Tarasiuk, O., Miloso, M., Cavaletti, G., et al. (2024). Evaluation of Histone Deacetylase 6 inhibitors as possible neuroprotectors against Paclitaxel-induced peripheral neurotoxicity. In Abstracts of the Fourteenth Annual Meeting of the Associazione italiana per lo studio del Sistema Nervoso Periferico (ASNP), 30 May – 1 June 2024, Trieste, Italy. Detail
Cavalloro, V., Marchesi, N., Linciano, P., Rossi, D., Campagnoli, L., Fossati, A., et al. (2024). Neurodegeneration: can metabolites from Eremurus persicus help?. FRONTIERS IN PHARMACOLOGY, 15, 1-13 [10.3389/fphar.2024.1309766]. Detail
Malacrida, A., Deschamps-Wright, M., Rigolio, R., Cavaletti, G., Miloso, M. (2023). Another Brick to Confirm the Efficacy of Rigosertib as Anticancer Agent. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 24(2) [10.3390/ijms24021721]. Detail